Erika Viel1,2, David Truong3, Laurie Rambach4, François Guinet5, André Vanoli1, Benjamin Schipman6, Djamel Harami7. 1. Medical Oncology, Ramsay Générale de Santé, Hopital Privé Sainte Marie, Chalon-sur-Saône, France. 2. Centre Georges-François Leclerc, Dijon, France. 3. Toussus-Le-Noble, France. 4. Medical Oncology, Centre Hospitalier William Morey, Chalon-sur-Saône, France. 5. Medical Oncology, Centre Hospitalier Galuzot, Montceau Les Mines, France. 6. Radiotherapy, Institut de Cancérologie de Bourgogne, Chalon-sur-Saône, France. 7. Oncology Department, Chalon-sur-Saône, France.
Abstract
Background: Chemotherapy-induced peripheral neuropathy (CIPN) can adversely affect completion of systemic anticancer treatment and cause long-term morbidity. To date, its physiopathology remains unclear, and treatments are rare and poorly performed. Auricular acupuncture has already offered interesting results in several symptoms. Objective: This study (AACIPN2020) assessed the efficacy of auriculotherapy in CIPN. Design: We used patients' systematically collected data of 2014-2016 in a medical oncology practice. The treatment was made according to guidelines of the interuniversity diploma and the cartography of the World Health Organization. Pain assessment according to the Common Terminology Criteria for Adverse Event scale was orally collected. Results: Seventy-three cancer patients were treated for CIPN. They had finished chemotherapy 24 weeks prior on average. They received on average 23 punctures at each appointment. Sixty-five percent of patients met satisfaction, with 31% with a real impact on their daily life. Efficacy appeared after one or two treatments for 96% of cases. Some patients continued treatment to maximize benefits. Conclusions: Auricular acupuncture is a safe and inexpensive method of CIPN treatment. It may be applied earlier in chemotherapy administration, and in a large variety of other symptoms. Clinical trial registration number: COS RGDS 2019 09 001. Copyright 2021, Mary Ann Liebert, Inc., publishers.
Background: Chemotherapy-induced peripheral neuropathy (CIPN) can adversely affect completion of systemic anticancer treatment and cause long-term morbidity. To date, its physiopathology remains unclear, and treatments are rare and poorly performed. Auricular acupuncture has already offered interesting results in several symptoms. Objective: This study (AACIPN2020) assessed the efficacy of auriculotherapy in CIPN. Design: We used patients' systematically collected data of 2014-2016 in a medical oncology practice. The treatment was made according to guidelines of the interuniversity diploma and the cartography of the World Health Organization. Pain assessment according to the Common Terminology Criteria for Adverse Event scale was orally collected. Results: Seventy-three cancer patients were treated for CIPN. They had finished chemotherapy 24 weeks prior on average. They received on average 23 punctures at each appointment. Sixty-five percent of patients met satisfaction, with 31% with a real impact on their daily life. Efficacy appeared after one or two treatments for 96% of cases. Some patients continued treatment to maximize benefits. Conclusions: Auricular acupuncture is a safe and inexpensive method of CIPN treatment. It may be applied earlier in chemotherapy administration, and in a large variety of other symptoms. Clinical trial registration number: COS RGDS 2019 09 001. Copyright 2021, Mary Ann Liebert, Inc., publishers.
Authors: Renate Barker; Alexander Kober; Klaus Hoerauf; Daniela Latzke; Sharam Adel; Zeev N Kain; Shu-Ming Wang Journal: Acad Emerg Med Date: 2005-12-19 Impact factor: 3.451
Authors: Anna-Liisa Kautio; Maija Haanpää; Arto Leminen; Eija Kalso; Hannu Kautiainen; Tiina Saarto Journal: Anticancer Res Date: 2009-07 Impact factor: 2.480
Authors: Julie E Hammack; John C Michalak; Charles L Loprinzi; Jeff A Sloan; Paul J Novotny; Gamini S Soori; Maria Tria Tirona; Kendrith M Rowland; Philip J Stella; Joanne A Johnson Journal: Pain Date: 2002-07 Impact factor: 6.961
Authors: Dawn L Hershman; Christina Lacchetti; Robert H Dworkin; Ellen M Lavoie Smith; Jonathan Bleeker; Guido Cavaletti; Cynthia Chauhan; Patrick Gavin; Antoinette Lavino; Maryam B Lustberg; Judith Paice; Bryan Schneider; Mary Lou Smith; Tom Smith; Shelby Terstriep; Nina Wagner-Johnston; Kate Bak; Charles L Loprinzi Journal: J Clin Oncol Date: 2014-04-14 Impact factor: 44.544
Authors: Andreas A Argyriou; Athanasios P Kyritsis; Thomas Makatsoris; Haralabos P Kalofonos Journal: Cancer Manag Res Date: 2014-03-19 Impact factor: 3.989